Cancer Colon Clinical Trial
Official title:
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice in the Outpatient Clinical Settings in the Appalachian Highlands
This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.
Study Rationale This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening. Although multiple screening options for CRC are available, participation and adherence to CRC screening remains below the national goal. CRC screening rate at the Ballad Health Mountain Laurel Internal Medicine clinic (site 1) is approximately 66%. A blood-based test (BBT) can provide a clinically important complement to standard-of-care (SOC) screening tests and address unmet medical needs for patients, especially for those who are non-adherent with current screening modalities. There are economic and societal benefits in early detection and prevention of CRC in a broader population than the one currently up to date with screening. The unmet need for maximum participation in CRC screening could be addressed with blood-based testing. Measuring subsequent provider experience and implementation behavior patterns involving blood based non-invasive cancer screening choices will also help to identify clinical utility of such test and implementation into clinical practice. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03179358 -
Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC
|
N/A | |
| Recruiting |
NCT03976960 -
Clinical and Biological Database in Colon Cancer and Colic Tumors
|
N/A | |
| Not yet recruiting |
NCT04079946 -
The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment
|
N/A | |
| Recruiting |
NCT05177484 -
Perioperative Iron for Colorectal Cancer (PICoC Study)
|
Phase 3 | |
| Completed |
NCT03951792 -
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
|
||
| Recruiting |
NCT06391749 -
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
|
||
| Recruiting |
NCT03722121 -
Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
|
||
| Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
| Recruiting |
NCT04972994 -
Laparoscopic Colectomies In Management of Colonic Cancers
|
N/A | |
| Recruiting |
NCT02542670 -
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.
|
N/A | |
| Completed |
NCT03688906 -
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
|
||
| Completed |
NCT05225870 -
Significance of Cortactin Expression in Colorectal Adenocarcinomas
|
N/A | |
| Completed |
NCT04400552 -
Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients
|
N/A | |
| Withdrawn |
NCT03185416 -
Early Palliative Care Integration in Interventional Cancer Care
|
N/A | |
| Completed |
NCT01533090 -
Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy
|
N/A |